Usual Source of Care and Outcomes Following Acute Myocardial Infarction
- 283 Downloads
The quality of the relationship between a patient and their usual source of care may impact outcomes, especially after an acute clinical event requiring regular follow-up.
To examine the association between the presence and strength of a usual source of care with mortality and readmission after hospitalization for acute myocardial infarction (AMI).
Prospective Registry Evaluating Myocardial Infarction: Event and Recovery (PREMIER), an observational, 19-center study.
AMI patients discharged between January 2003 and June 2004.
The strength of the usual source of care was categorized as none, weak, or strong based upon the duration and familiarity of the relationship. Main outcome measures were readmissions and mortality at 6 months and 12 months post-AMI, examined in multivariable analysis adjusting for socio-demographic characteristics, access and barriers to care, financial status, baseline risk factors, and AMI severity.
Among 2,454 AMI patients, 441 (18.0 %) reported no usual source of care, whereas 247 (10.0 %) and 1,766 (72.0 %) reported weak and strong usual sources of care, respectively. When compared with a strong usual source of care, adults with no usual source of care had higher 6-month mortality rates [adjusted hazard ratio (aHR) = 3.15, 95 % CI, 1.79–5.52; p < 0.001] and 12-month mortality rates (aHR = 1.92, 95 % CI, 1.19–3.12; p = 0.01); adults with a weak usual source of care trended toward higher mortality at 6 months (aHR = 1.95, 95 % CI, 0.98–3.88; p = 0.06), but not 12 months (p = 0.23). We found no association between the usual source of care and readmissions.
Adults with no or weak usual sources of care have an increased risk for mortality following AMI, but not for readmission.
KEY WORDSdoctor and patient relationship usual source of care myocardial infarction
We gratefully acknowledge support from the grant U01-HL105270-03 (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute. Dr. Krumholz was supported by grant U01 HL105270-03 (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute. Dr. Ross is supported by the National Institute on Aging (K08 AG032886) and by the American Federation for Aging Research through the Paul B. Beeson Career Development Award Program. CV Therapeutics and CV Outcomes, a 501(c)(3) corporation funded the PREMIER registry.
American Heart Association: Quality of Care and Outcomes Research, Poster Presentation, 2011.
Conflict of Interests
Drs. Krumholz and Ross work under contract with the Centers for Medicare & Medicaid Services to develop and maintain performance measures and are the recipients of a research grant from Medtronic, Inc., through Yale University. Dr. Krumholz is chair of a cardiac scientific advisory board for UnitedHealth, and Dr. Ross is a member of a scientific advisory board for FAIR Health. Dr. Spertus reports funding from NIH, AHA, ACCF, Gilead, Genentech, Amorcyte, Eli Lilly and Abbott Vascular. He serves as a consultant to United Healthcare, Genentech, Gilead, Novartis, Janssen, and Amgen.
- 1.Pancholi M. Reasons for Lacking a Usual Source of Care: 2001 Estimates for the US Civilian Noninstitutionalized Population. www.meps.ahrq.gov/mepsweb/data_files/publications/st32/stat32.pdf. Accessed January 22, 2014.
- 2.NCHS. Early release of selected estimates based on data from the 2010 National Health Interview Survey. Hyattsville, MD: Centers for Disease Control and Prevention; 2010.Google Scholar
- 12.Spatz ES, Ross JS, Desai MM, Canavan ME, Krumholz HM. Beyond insurance coverage: usual source of care in the treatment of hypertension and hypercholesterolemia. Data from the 2003–2006 National Health and Nutrition Examination Survey. Am Heart J. 2010;160(1):115–121.PubMedCentralPubMedCrossRefGoogle Scholar
- 13.Starfield B. Primary Care: Balancing Health Needs, Services, and Technology. New York: Oxford University Press; 1998.Google Scholar